Cargando…

Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?

INTRODUCTION: We analyzed whether expansion of existing active surveillance (AS) protocols to include men with biopsy Gleason score (GS) 3+4 prostate cancer (PCa) would significantly alter pathologic and biochemical outcomes of potential candidates of AS. METHODS: Among patients who underwent radica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Ohseong, Kim, Tae Jin, Lee, In Jae, Byun, Seok-Soo, Lee, Sang Eun, Hong, Sung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182658/ https://www.ncbi.nlm.nih.gov/pubmed/25268898 http://dx.doi.org/10.1371/journal.pone.0109031

Ejemplares similares

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
por: Pham, Duc Minh, et al.
Publicado: (2020)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

Clinical Significance of a Large Difference (≥ 2 points) between Biopsy and Post-prostatectomy Pathological Gleason Scores in Patients with Prostate Cancer
por: Yoo, Changhee, et al.
Publicado: (2011)

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6–7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8–10
por: Chung, Doo Yong, et al.
Publicado: (2019)

Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy
por: Lee, Sangchul, et al.
Publicado: (2015)

The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients
por: Oh, Jong Jin, et al.
Publicado: (2014)

Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy
por: Oh, Jong Jin, et al.
Publicado: (2016)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

The correlation between the gleason score of the biopsy and that of the prostatectomy patch
por: Bai, W., et al.
Publicado: (2021)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
por: Oh, Jong Jin, et al.
Publicado: (2021)

Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
por: Kim, Hwanik, et al.
Publicado: (2021)

pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
por: Kim, Sung Jin, et al.
Publicado: (2011)

Oncologic Outcomes of Patients With Gleason Score 7 and Tertiary Gleason Pattern 5 After Radical Prostatectomy
por: Leng, Yi-Hsueh, et al.
Publicado: (2013)

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy
por: Fiorentino, Vincenzo, et al.
Publicado: (2020)

Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2017)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

TRUS-Guided Target Biopsy for a PI-RADS 3–5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis
por: Chung, Jae Hoon, et al.
Publicado: (2022)

Erratum: pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
Publicado: (2011)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin
por: Lee, Jung Keun, et al.
Publicado: (2016)

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
por: Rapiti, Elisabetta, et al.
Publicado: (2013)

Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
por: Tadayyon, Farhad, et al.
Publicado: (2013)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
por: Jin, Byung-Soo, et al.
Publicado: (2015)

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation
por: He, Biming, et al.
Publicado: (2016)

Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?
por: Wei, Cheng, et al.
Publicado: (2021)

Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
por: Hu, Xuanhan, et al.
Publicado: (2022)

Upgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: An Indian experience
por: Nayyar, Rishi, et al.
Publicado: (2010)

Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study
por: Pereira, Renan A, et al.
Publicado: (2015)

Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
por: Barsky, Andrew R., et al.
Publicado: (2020)

Prospective Analysis on the Relation between Pain and Prostate Volume during Transrectal Prostate Biopsy
por: Yun, Tae Jin, et al.
Publicado: (2007)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Radiomics for Gleason Score Detection through Deep Learning
por: Brunese, Luca, et al.
Publicado: (2020)

Automated Gleason Scoring and Tumor Quantification in Prostate Core Needle Biopsy Images Using Deep Neural Networks and Its Comparison with Pathologist-Based Assessment
por: Ryu, Han Suk, et al.
Publicado: (2019)

Comparison of robotic and open partial nephrectomy for highly complex renal tumors (RENAL nephrometry score ≥10)
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sgqq7g0v1v2b25cqsgmtpt4us8